EGFR and lung carcinoma: The recent success in suppressing the growth of cultured lung cancer cells with activating EGFR mutations by siRNA (Sordella et al, 2004) unveiled the sensitivity of siRNA-based approaches in distinguishing drivers of tumour growth.